FDA inspection
Sartorius Stedim North America, Inc.: FDA inspection ending Jun 23, 2023
FDA inspection 1208719 · Voluntary Action Indicated (VAI) · Cambridge, MA
Key facts
| Inspection ID | 1208719 |
|---|---|
| Firm | Sartorius Stedim North America, Inc. |
| FEI number | 3013367666 |
| Address | 245 1st St Ste 250 |
| City | Cambridge |
| State | MA |
| ZIP | 02142 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Jun 23, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data